Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine.

Abstract

Blood-based therapeutics are cellular or plasma components derived from human blood. Their production requires appropriate selection and treatment of the donor and processing of cells or plasma proteins. In contrast to clearly defined, chemically synthesized drugs, blood-derived therapeutics are highly complex mixtures of plasma proteins or even more… (More)

Topics

Cite this paper

@article{Thiele2007ProteomicsOB, title={Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine.}, author={Thomas Thiele and Leif Steil and Uwe Voelker and Andreas Greinacher}, journal={BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy}, year={2007}, volume={21 3}, pages={179-93} }